Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
16 June 2022Website:
http://heartsciences.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 05 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
HSCS Latest News
Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been granted Indian Patent Application 201817014481 by the Indian Patent Office (IPO). To date, HeartSciences has been granted nine US patents and 35 international patents for a total of 44 granted patents.
Heart Test Laboratories (NASDAQ: HSCS ) stock is falling hard on Wednesday after the medical technology company announced a secondary offering for its shares. Heart Test Laboratories notes that this is a resale of 34,684,859 shares of HSCS stock by a few shareholders.
Heart Test Laboratories (NASDAQ: HSCS ) stock is rising higher on Wednesday without any clear news from the maker of cardiovascular diagnostic devices. There have been no new press releases or filings with the Securities and Exchange Commission that explain why HSCS stock is rising higher today.
Heart Test Laboratories (NASDAQ: HSCS ) stock is on the move Thursday after announcing an agreement with the Icahn School of Medicine at Mount Sinai. This new agreement has Heart Test Laboratories' HeartSciences working with Icahn Mount Sinai to commercialize electrocardiographic artificial intelligence ( AI ) algorithms and assets.
Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson, will participate in a fireside chat at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 11:30 am ET.
What type of business is Heart Test Laboratories?
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
What sector is Heart Test Laboratories in?
Heart Test Laboratories is in the Healthcare sector
What industry is Heart Test Laboratories in?
Heart Test Laboratories is in the Medical Devices industry
What country is Heart Test Laboratories from?
Heart Test Laboratories is headquartered in United States
When did Heart Test Laboratories go public?
Heart Test Laboratories initial public offering (IPO) was on 16 June 2022
What is Heart Test Laboratories website?
https://heartsciences.com
Is Heart Test Laboratories in the S&P 500?
No, Heart Test Laboratories is not included in the S&P 500 index
Is Heart Test Laboratories in the NASDAQ 100?
No, Heart Test Laboratories is not included in the NASDAQ 100 index
Is Heart Test Laboratories in the Dow Jones?
No, Heart Test Laboratories is not included in the Dow Jones index
When does Heart Test Laboratories report earnings?
Next earnings report date is not announced yet